EUVIMEDEUVIMED entdecken
Übersichtsarbeit

A review on drug repurposing applicable to obesity

Feng Chen iD, Kai Jing iD, Zhen Zhang iD, Xia Liu iD

Obesity Reviews · 2025-02 · 26 (2)

DOI: 10.1111/obr.13848 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Obesity Reviews, online erschienen am 09.10.2024. Verfasst von Feng Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, School of Pharmacy, Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Drug Repositioning, Obesity, Anti-Obesity Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 140 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Program of Shanghai Academic/Technology Research Leader, Program of Shanghai Academic Research Leader.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is a major public health concern and burden on individuals and healthcare systems. Due to the challenges and limitations of lifestyle adjustments, it is advisable to consider pharmacological treatment for people affected by obesity. However, the side effects and limited efficacy of available drugs make the obesity drug market far from sufficient. Drug repurposing involves identifying new applications for existing drugs and offers some advantages over traditional drug development approaches including lower costs and shorter development timelines. This review aims to provide an overview of drug repurposing for anti‐obesity medications, including the rationale for repurposing, the challenges and approaches, and the potential drugs that are being investigated for repurposing. Through advanced computational techniques, researchers can unlock the potential of repurposed drugs to tackle the global obesity epidemic. Further research, clinical trials, and collaborative efforts are essential to fully explore and leverage the potential of drug repurposing in the fight against obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug RepositioningObesityAnti-Obesity AgentsHumans

Stichwörter der Autor:innen

anti‐obesity medicationsdrug discoverydrug repurposingobesity

Substanzen

Anti-Obesity Agents

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, School of Pharmacy, Naval Medical University, Shanghai, China.
  • Department of Nutrition and Food Hygiene, Faculty of Naval Medicine, Naval Medical University, Shanghai, China.

ORCID-Profile: Feng Chen, Kai Jing, Zhen Zhang, Xia Liu

Förderung

  • National Natural Science Foundation of China
  • Program of Shanghai Academic/Technology Research Leader
  • Program of Shanghai Academic Research Leader

Zitieren

APA

Chen, F., Jing, K., Zhang, Z., & Liu, X. (2025). A review on drug repurposing applicable to obesity. Obesity Reviews, 26(2). https://doi.org/10.1111/obr.13848

Vancouver

Chen F, Jing K, Zhang Z, Liu X. A review on drug repurposing applicable to obesity. Obesity Reviews. 2025;26(2). doi:10.1111/obr.13848

BibTeX
@article{Chen2025,
  author = {Chen, Feng and Jing, Kai and Zhang, Zhen and Liu, Xia},
  title = {A review on drug repurposing applicable to obesity},
  journal = {Obesity Reviews},
  year = {2025},
  volume = {26},
  number = {2},
  doi = {10.1111/obr.13848}
}
Kostenlos starten →